|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 239/48 | |
| C07D 409/12 | |||
| C07D 401/12 | |||
| C07D 405/12 | |||
| C07D 403/12 | |||
| A61K 31/505 | |||
| A61K 31/506 | |||
| C07D 251/48 | |||
| A61P 35/00 |
| (11) | Patento numeris | 2418205 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10183683.1 |
| Europos patento paraiškos padavimo data | 2005-06-23 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-02-15 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2014-01-22 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 582425 P | 2004-06-24 | US | |
| 0512324 | 2005-06-16 | GB |
| (72) |
Ding, Qiang, US
Gray, Nathanael Schiander, US
Li, Bing, US
Liu, Yi, US
Sim, Taebo, US
Uno, Tetsuo, US
Zhang, Guobao, US
Pissot Soldermann, Carole, FR
Breitenstein, Werner, CH
Bold, Guido, CH
Caravatti, Giorgio, CH
Furet, Pascal, FR
Guagnano, Vito, CH
Lang, Marc, FR
Manley, Paul W., CH
Schoepfer, Joseph, CH
Spanka, Carsten, DE
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
IRM LLC, Hurst Holme 12 Trott Road, Hamilton HM 11, BM |
| (54) | Pyrimidine urea derivatives as kinase inhibitors |
| Pyrimidine urea derivatives as kinase inhibitors |